Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lynestrenol is a synthetic progestin (progestogen) used primarily for contraception and the treatment of menstrual disorders. It acts as a prodrug, being rapidly converted in the liver to norethisterone, its active metabolite, which is a potent agonist of the progesterone receptor. Lynestrenol itself does not bind directly to the progesterone receptor but exerts its effects through norethisterone. Its main clinical uses include oral contraception (alone or with estrogen), management of menstrual cycle irregularities, endometriosis treatment, and hormone replacement therapy in menopausal women. The contraceptive effect is achieved mainly by increasing cervical mucus viscosity to inhibit sperm penetration and by suppressing ovulation[1][2][3][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lynestrenol.